Member Info for NoOneKnows

Alba website appears as normal to me with the coins at the top.

I think they were hoping to be producing in 2027 but they need to raise a lot of funds which I could happen this year.

The shares would be sold.

You obviously don't Robbie.

You've obviously not been here long Khorud any good news rumours always turn out to be mythical.

I wondered but the drop was on relatively small trades money wise.

My best guess is they are orders that have been placed and then cancelled but that is a guess.

I've been here for about 3 years so not as underwater as some and it has been slow progress due to covid and then NRW but the NRW is a hurdle we got through. Now we have dewatered got the mine safe and now we are at a point of finding out what gold is down there. We know there is gold and hopefully in the next few months we get processing increased and actually have a producing mine on our hands. Good luck to all long term and patient holders.

Last year(not sure when exactly) they said Unilever could take up to 2 years but I would expect other contracts are closer.

Its just drifting down on no major news as many AIM listed companies do.. the trading update was positive and this year is likely to be news rich as time goes on.

Maybe producig a lateral flow test is going to be the game changer ?

Technical update from Aptamer 5th december...

Aptamer and Neuro-Bio have reached a key milestone in developing an Alzheimer's disease diagnostic test. Optimer binders targeting Alzheimer's biomarkers have been successfully integrated into a biosensor test and shown positive results in the analysis of clinical samples. Tests using spinal fluid and saliva samples from Alzheimer's patients and healthy controls demonstrated robust biomarker detection and a statistically significant differentiation between Alzheimer's patients and healthy controls.

These results demonstrate the diagnostic potential of Optimers and support their integration into point-of-care testing for clinical applications. Additionally, efforts are underway to adapt this technology for at-home diagnostic use via lateral flow tests, expanding its market potential and accessibility. The diagnostic market value for Alzheimer's disease was worth over $4.5 billion in 2023.

Maybe none but if Neuro-Bio are involved they are working with aptamer.

Https://news.sky.com/story/simple-blood-test-that-could-detect-dementia-at-early-stage-begins-trial-in-nhs-clinics-13298429#:~:text=A%20simple%20blood%20test%20that,processing%20at%20an%20early%20stage.

There is an Oxford university link so maybe Neuro-bio(spun out of Oxford university) are involved idk. I'm sure we'll find out at some point.

I think this is still under the radar for many people, so I had another small top up while I can at these levels.

The upside is looking pretty good and the risk relatively small.... doesn't happen often with many small AIM companies.

With all the projects progressing well and a significant cash runway I am feeling confident we have good times ahead!

Should get half-year trading update soon, probably next week which is something to look forward to.

We got the half-year trading update on 5th of Feb last year so not long to wait for this years, I'm expecting it to be positive with the directors buying recently.

Look 5 years down the line and the sp could easily be 100x todays price or more... and I would be more than happy to keep topping up at under 1p when I have spare cash.